Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Guardant Health Inc (GH)

Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Guardant Health: Q1 Earnings Snapshot

Guardant Health: Q1 Earnings Snapshot

GH : 24.96 (-1.58%)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024

Stocks that traded heavily or had substantial price changes on Friday: Sprouts, Block rise; Booking Holdings, Insulet fall

SNBR : 15.42 (-2.34%)
SFM : 79.16 (+0.75%)
ACCO : 5.08 (-1.36%)
GH : 24.96 (-1.58%)
DISCA : 24.43 (+5.90%)
BKNG : 3,759.40 (+1.38%)
PODD : 183.68 (-1.92%)
Guardant Health: Q4 Earnings Snapshot

Guardant Health: Q4 Earnings Snapshot

GH : 24.96 (-1.58%)
Cathie Wood Is Selling This Stock: Should You?

This company hasn't performed well in the past 12 months.

EXAS : 51.24 (+1.71%)
GH : 24.96 (-1.58%)
4 Cathie Wood Stocks Wall Street Thinks Will Skyrocket 83% to 168% in 2024

Even if Wall Street is wrong about these stocks in the new year, Cathie Wood could still be right about them over the long run.

ARKK : 45.37 (-0.18%)
ARKW : 78.33 (+0.18%)
GH : 24.96 (-1.58%)
ARKG : 26.50 (-0.11%)
BEAM : 24.80 (+0.73%)
DNA : 0.7743 (-3.89%)
NTLA : 25.99 (-0.88%)
Guardant Health: Q3 Earnings Snapshot

Guardant Health: Q3 Earnings Snapshot

GH : 24.96 (-1.58%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.1227 (+1.32%)
TELO.VN : 0.180 (+5.88%)
GH : 24.96 (-1.58%)
NTRA : 106.74 (+0.26%)
DGX : 144.74 (+0.28%)
NEO : 14.83 (+0.20%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

/PRNewswire/ -- Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell that produces antibodies to fight...

TELO.VN : 0.180 (+5.88%)
TDSGF : 0.1227 (+1.32%)
GH : 24.96 (-1.58%)
NTRA : 106.74 (+0.26%)
DGX : 144.74 (+0.28%)
NEO : 14.83 (+0.20%)
1 Beaten-Down Healthcare Stock to Buy and Hold For 10 Years

This company's fight against a deadly disease could pay off.

GH : 24.96 (-1.58%)
Which Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health?

The oncology diagnostic companies are looking for better solutions in early cancer diagnosis.

EXAS : 51.24 (+1.71%)
GH : 24.96 (-1.58%)

Barchart Exclusives

Is It Too Late to Buy the Best Dow Stock of 2024?
As the Dow Jones reaches record highs and American Express leads the pack, is it too late to snag a piece of the stock? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar